Its a marketing trope often repeated in viral,feel-good commercials for genetic ancestry tests: If we only knew just how related we all were, even distantly, then prejudice and racism would cease to exist.

But new research at the University of California, Los Angeles, finds the opposite: White supremacists do not especially care what their genetic ancestry tests show, if they reveal anything that doesnt conform with their claimed white heritage. At the same time, these genetic tests may actually be exciting to white supremacists because it gives them a scientific argument for the diversity of the European race, which helps them appropriate the language of diversity and multiculturalism for hateful purposes.

The findings, presented at the American Sociological Association this week and to be published in a forthcoming journal article, are a sober reminder that it takes a lot more than genetic proof of multiethnic ancestry to dissuade hard-core racists from their hateful ideology. In fact, the tests may bolster some of their beliefs.

We cant rely on genetic information to turn white nationalists away from their views, researcher Aaron Panofsky wrote in an email to HuffPost. I saw a tweet that said we should crowdfund [genetic ancestry tests] for these guys and that would end the movement. I think that is completely wrong and the genetics cant save us.

In a video posted on the Ancestry.com YouTube page, one participant says, There would be no such thing as, like, extremism in the world if people knew their heritage like that.

Genetic ancestry tests require people to spit into tubes and send the saliva samples to a lab for analysis. A few weeks later, they are directed to a website that reveals their genetic heritage. All genetic ancestry companies compare a persons genome with a proprietary database of reference populations, and show percentages of DNA defined racially, ethnically, continentally, or by modern nation-states. So, a person may be 87 percent East Asian in one companys test, but 67 percent Chinese in another companys test. The services also analyze mitochondrial DNA passed down from the mother and father to assess how ancestors may have migrated over time.

For genealogy hobbyists, its a good way to search for long-lost relatives to complete the family tree. Recent news articles, however, have highlighted a dark side of these tests, as they can also reveal long-hidden genetic secrets, like true paternity or the fact that babies may have been switched at birth.

While genetic ancestry tests have the veneer of scientific accuracy, they have come under attack by scientists. As Panofsky and Donovan put it in their forthcoming paper, the tests trade on the authority of science but do not adhere to scientific standards of openness and accountability. Further, there are no industry standards or uniformity. Each company has their own trademarked panel of population samples, algorithms and DNA markers, and consumers may get different or even conflicting results from company to company. And this confusion doesnt even get into the messiness of the history of human civilization: What would 75 percent Spanish mean with the nation-state of Spains history of invasions, wars and immigration patterns?

To examine how white supremacists use these tests, Panofsky and co-author Joan Donovan scoured the discussion boards of Stormfront, the oldest online forum for white supremacists, and identified 153 people who had posted the results of their genetic ancestry tests for comment.

Fifty-three of the people who posted were happy about good news that confirmed their European heritage, 49 posted their results because they were confused or disappointed, and 51 posted results without comment, although other forum members were free to discuss them.

Panofskys first observation was that, despite the promises of those sappy viral videos, not a single person renounced their hateful beliefs in reaction to their test results. He also was surprised that Stormfront members were willing to post their bad news results, even though the rules of membership are that people must have all-white, non-Jewish ancestry.

For some white supremacists who found links to Jewish or other non-European people groups, feedback from the forum ranged from never breed, to more gentle assurances that as long as they didnt see Jew when they looked in the mirror, they could claim whiteness.

Finally, Panofsky observed that members were having in-depth discussions in an attempt to explain away undesirable ancestry by suggesting the test itself was either invalid (a Jewish conspiracy to confuse white people, for example) or the tests methodology and statistical analysis were flawed.

They have very sophisticated interpretations that are based on statistical, genetic, and historical reasoning, Panofsky said. The conclusions and interpretations they make are often not the ones professional geneticists, biological anthropologists, and historians would make, but these interpretations are not ignorant or uneducated.

Perhaps most disturbing, some white supremacists are taking news of their heritage from multiple European countries and using it to create a pallete of diversity that doesnt include people of color.

A persons test might come back 30 percent English, 20 percent Danish, 40 percent German, etc., and this looks like great diversity within Europeans without people of color being involved, Panofsky explained. Already some white nationalists portray white people as the true people of color (red hair, blond, brown, and black hair; blue, green, and brown eyes; pale to olive skin etc.), while seeing non-whites as all the same.

Regardless of how white supremacists see it, the historical definition ofwhiteness is a socially constructed, ever-shifting categorization. In the 19th century, superior whites were of Saxon stock, and didnt include the Irish, Italian or Eastern European Jews. Over time, some of these groups gained entry into whiteness,while others didnt.

Now, it appears that genetic ancestry tests complicate whiteness even further and not in the way that genetic ancestry testing companies anticipated.

America does not do a good job of tracking incidents of hate and bias. We need your help to create a database of such incidents across the country, so we all know whats going on. Tell us your story.

Excerpt from:
White Supremacists Are Using Genetic Ancestry Tests For A Creepy Purpose - HuffPost

Day Trading Ideas, RSI overbought/oversold signals - Buy Gilead Sciences, Inc. (GILD) stock, JD.Com Inc(ADR) (JD) stock and sell Atossa Genetics Inc (ATOS) stock.

Here is a summary of today's top day trading ideas based on popular momentum indicator Relative Strenght Index (RSI). The RSI indicator can be used to identify buy/sell signals in the market and today's most popular stocks flashing buy/sell signals using RSI indicator include Foster City, California-basedbiotech company Gilead Sciences (NASDAQ:GILD), Chinese e-commerce company JD.com (NASDAQ:JD) and Seattle-based healthcare firmAtossa Genetics (NASDAQ:ATOS). If you want to see the complete set of technical tradingideas for todaycheck them out here.

Shares of Gilead Sciences have failed to sustain the rally after theQ2 2017 earnings release in the last week of July. In the month of August, GILD stock has gradually trended downwards and is down nearly 5%. Investors would be hoping for a rebound soon, as the companyseems to be getting things sorted, posting better than expected earnings in the second quarter. The GILD stock may soon end its downward trend, as theas the stock is in oversold territory. The RSI indicator is flashing an oversold signal for Gilead stock. The RSI value of the stock has fallen to 27.22, which is below the commonly use oversold RSI measure of 30. The rebound in Gilead shares couldget a further boost by the fact that the share price is very close to the lower Bollinger Band, implying that the indicator could flash an oversold signal as well. A rebound in Gilead shares is most likely around the corner.

Shares of JD.Com have had an amazing year, rising by a whopping 89% until last week. From August 9th, JD stock has been trending downwards going into its earnings. In spite of the massive correction of more than 14%, the stock is up more than 60% in the Year-to-Date. JD.com delivered better than expected results in its Q2 earnings, but the downward pressure increased on account of widened Q2 losses. However, it might be time to buy JD stock again. The fundamental story of JD has not changed much, as the company has forecasted strong revenue growth of36% to 40%for the third quarter. Popular momentum indicators like RSI and Bollinger Bands are both flashing an oversold signal. The RSI value of the stock stands at 29.87, just below the common oversold threshold measure of 30. For JD.Com stock, the Bollinger Bands indicator is also flashing an oversold signal. The share price of the company has already fallen below the lower Bollinger Band to flash an oversold signal. This further increases the probability that JD stock may soon resume its uptrend. The combination of the above two signals is considered as a strong signal.

Looking for fundamentally better tech stocks? Check out Amigobulls'top stock picksfrom the tech sector, which have beaten the NASDAQ by over 140%. Interested in automotive stocks? Then, we also have ourtop picks from the auto sector, which have beaten the S&P 500 by a massive 234%.

Originally posted here:
Buy Gilead Sciences, JD.Com And Sell Atossa Genetics - Top RSI Trades For Today - Amigobulls

Seattle Genetics, Inc. SGEN announced that the FDA has accepted its supplemental Biologics License Application (BLA) for Adcetris (brentuximab vedotin) in patients with cutaneous T-cell lymphoma (CTCL). Additionally, the FDA granted Priority Review for the application and has set a target action date of Dec 16, 2017.

Adcetris is the only marketed product at Seattle Genetics. The drug is approved for relapsed Hodgkin lymphoma and relapsed systemic anaplastic large cell lymphoma (sALCL) in the U.S., the EU and Japan. It is also approved in the U.S. for the treatment of patients suffering from classical Hodgkin lymphoma, who are at high risk of relapse or progression as post-autologous hematopoietic stem cell transplantation (auto-HSCT) consolidation.

Notably, shares of the company have declined 11.4% against the Zacks classified industry's gain of 7.4% on a year-to-date basis.

The submission of the supplemental BLA was mainly based on positive data from the phase III trial, ALCANZA and two phase II investigator-sponsored trials in patients with CTCL. Interestingly, the ALCANZA study achieved both the primary and secondary endpoints.

The study showed that CTCL patients treated with Adcetris had superior outcomes across all primary and secondary endpoints compared with patients in the control arm, who were treated with either methotrexate or bexarotene standard of care agents.

Furthermore, the FDA granted Breakthrough Therapy Designation (BTD) to Adcetris for the treatment of patients with CD30-expressing mycosis fungoides and primary cutaneous anaplastic large cell lymphoma, who require systemic therapy and have received one prior systemic therapy in November 2016.

Adcetris, generated revenues of $74.3 million, up 12.3% year over year in the second quarter of 2017 and is expected to generate sale in the range of $290 million to $310 million in the U.S. and Canada in 2017. Seattle Genetics is also working on expanding the drug's label which will be a further boost for the company's revenues.

Seattle Genetics, Inc. Price

Seattle Genetics, Inc. Price | Seattle Genetics, Inc. Quote

Zacks Rank & Stocks to Consider

Seattle Genetics currently holds a Zacks Rank #3 (Hold). Some better-ranked stocks in health care sector include Alexion Pharmaceuticals, Inc. ALXN , Regeneron Pharmaceuticals, Inc. REGN and Sanofi SNY . While Alexion and Regeneron sport a Zacks Rank #1 (Strong Buy), Sanofi holds Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Alexion Pharmaceuticals' earnings per share estimates have moved up from $4.55 to $4.77 for 2017 and from $5.49 to $6.43 for 2018 over the last 30 days. The company delivered positive earnings surprises in three of the trailing four quarters, with an average beat of 12.26%. The share price of the company has increased 11.7% year to date.

Regeneron's earnings per share estimates have increased from $10.52 to $13.81 for 2017 and from $12.10 to $14.54 for 2018 over the last 30 days. The company pulled off positive earnings surprises in two of the trailing four quarters, with an average beat of 6.29%. The share price of the company has increased 27.6% year to date.

Sanofi's earnings per share estimates have moved up from $3.20 to $3.31 for 2017 and from $3.36 to $3.38 for 2018 over last 30 days. The company came up with positive earnings surprises in three of the trailing four quarters, with an average beat of 5.10%. The share price of the company has increased 19.7% year to date.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing and exclusive of fees, it can turn thousands into millions of dollars. This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today. Learn more >>

Alexion Pharmaceuticals, Inc. (ALXN): Free Stock Analysis Report

Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report

Seattle Genetics, Inc. (SGEN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Original post:
Seattle Genetics' Adcetris Granted Priority Review by FDA - Nasdaq

U.S. oncology specialist Cancer Genetics will pay $12 million to buy out Australian contract research organization vivoPharm as it looks to bolster its offerings.

Cancer Genetics (CGI) says the deal will boost its position as a premier leader for oncology discovery, in vivo and in vitro drug development and early phase clinical trial testing for biotechnology and pharmaceutical companies.

It buys into vivoPharm, a firm that has spent 10 years offering discovery and preclinical services to support drug development, target validation and biomarker analysis, with a big focus on immuno-oncology.

The CRO currently works with more than 40 biopharmas across five continents, in more than 55 studies and trials. Its led by Ralf Brandt, who will be fully integrated as the flagship in CGIs discovery services offering, according to its new owner, serving as the president of this unit.

The deal closed this week, and sees its 32 staffers subsumed into CGI. The price paid, $12 million, includes $1.2 million in cash, with the remaining 90% in the form of shares of CGI common stock. The company has also signed an equity financing deal for up to $16 million to fund the takeover.

The acquisition is expected to be immediately accretive, adding both revenue and income, CGI said in a statement.

The combination of capabilities is expected to create considerable business opportunities in both pre-clinical studies and immuno-oncology clinical trials, to further accelerate CGIs strategy to be the premier partner of choice for oncology innovation and development from bench to bedside.

More:
Cancer Genetics pays $12M for Australian CRO vivoPharm - FierceBiotech

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Baylor Genetics today announced that they have entered into a licensing agreement to offer a next-generation sequencing (NGS) library prep assay that enables efficient sequencing of the CFTR (cystic fibrosis transmembrane conductance regulator) gene.

Under the agreement, Fluidigm obtains the rights to commercialize the CFTR library prep assay developed by Baylor Genetics for research use with the Juno automated microfluidic system. The targeted NGS library prep assay enables accurate identification of variants from each of the 27 exons in the CFTR gene and selected intronic regions. When combined with Fluidigm microfluidics, this solution has the potential to significantly simplify complex labor-intensive laboratory workflows and improve the efficiency of CFTR sequencing.

Cystic fibrosis (CF) is a complex multisystem disease that is caused by mutations in the CFTR gene and affects over 70,000 individuals worldwide. Over 2,000 variants have been identified within the CFTR gene. The detection frequency of these variants has been shown to vary by ancestry. Traditional genotyping methods typically focus on a subset of these variants and are limited in their ability to identify less common and new CFTR variants across large, diverse populations.

Next-generation sequencing offers a more comprehensive approach to CFTR genetic analysis by allowing a more complete view of the sequence. Targeted sequencing library prep workflows, however, can be very labor-intensive. With the application of Fluidigm automated microfluidics technology, NGS library preparation can be streamlined to provide significant efficiencies.

The combination of a rapid, accurate library prep workflow, followed by NGS, has allowed us to create a streamlined, cost-effective approach for CFTR sequencing. We realized the benefit of the microfluidic technology, and our agreement with Fluidigm has allowed us to move forward quickly. Our work with Fluidigm microfluidic technology will help us to further enhance our offerings and capabilities, said Shashikant Kulkarni, Chief Scientific Officer of Baylor Genetics.

Baylor Genetics is an industry leader in the development of high-quality genetic assays. We are excited at the opportunity to bring the benefits of this CFTR library prep assay to the larger community, said Chris Linthwaite, President and CEO of Fluidigm. This agreement represents a great example of how we are developing an expanding menu of high-value genetic assays for use with Fluidigm microfluidic systems to improve the future of health care.

About Baylor Genetics

Baylor Genetics has been helping health care providers solve the most complex cases of genetic disease for over 35 years and we are proud to be affiliated with the #1 NIH-funded genetics program at the Baylor College of Medicine. By bridging academic and operational excellence, Baylor Genetics offers the medical community a vast testing menu, the most thorough interpretations, access to experts, and the confidence to provide patients with answers. Baylor Genetics is located in Houstons Texas Medical Center with over 200 employees and over 3,000 tests available to clients in all 50 states and internationally. Our lab is well-equipped with cutting-edge diagnostic equipment, allowing us to efficiently generate the most accurate clinical genetic data. Through rigorous quality assurance, daily and monthly conferences, and close relationships with clinical partners, Baylor Genetics continuously improves diagnostic precision.

About Fluidigm Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and singlecell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

We use our website (www.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (https://www.facebook.com/fluidigm), and LinkedIn page (https://www.linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases, SEC filings, public conference calls, and webcasts.

Fluidigm, the Fluidigm logo, and Juno are trademarks or registered trademarks of Fluidigm Corporation.

Forward-Looking Statement for Fluidigm

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding anticipated development of sequencing productsand the potential impact of such products. Forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results, including but not limited to, risks relating to uncertainties in contractual relationships and international regulated markets; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; the uncertain regulatory environment; potential product performance and quality issues; intellectual property risks; competition; interruptions or delays in the supply of components or materials for, or manufacturing of, Fluidigm products; and risks associated with international operations. Information on these and additional risks, uncertainties, and other information affecting Fluidigm business and operating results are contained in Fluidigms Annual Report on Form 10-K for the year ended December 31, 2016, and in its other filings with the Securities and Exchange Commission, including Fluidigms Quarterly Report on Form 10-Q for the quarter ended June 30, 2017. These forward-looking statements speak only as of the date hereof. Fluidigm disclaims any obligation to update these forward-looking statements except as may be required by law.

Read the original:
Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System - GlobeNewswire (press release)

In BriefResearchers have established a new method of controlling the movements of mice in an attempt to better understand the workings of the brain. Genetic engineered mouse brains respond to temperature and electric current with the flick of a switch. This research could help people with mental health issues.

A team of researchers at the University of Buffalo has used magneto-thermal stimulation to control the movements of mice.

These results were achieved working with mice that had been genetically engineered such that targeted neurons would produce ion channels sensitive and even receptive to temperature. Nanoparticles consisting of a cobalt-ferrite core coated in manganese ferrite were injected into the brain, attaching themselves to neurons.

Applying an alternating magnetospherecauses the magnetization of these nanoparticles to switch back and forth, raising their temperature. As a result, the ion channels open up, causing the associated neurons to fire.

This research isnt really about bossing mice around its about linking specific parts of the brain to the movements and behaviors they control. Understanding how the brain works in this respect could help develop treatments for conditions that affect particular groups of neurons, including Parkinsons disease, dystonia, and traumatic brain injuries.

There is a lot of work being done now to map the neuronal circuits that control behavior and emotions, said Professor of Physics Arnd Pralle, the lead researcher. The technique we have developed could aid this effort greatly.

Techniques like transcranial magnetic stimulation already allow us to tinker with the brain, and research has shown that Optogenetics can be used to make major changes to the behavior of mice in a lab setting. However, magneto-thermal stimulation is considered less invasive than these other methods. No evidence of brain damage was found in the mice used during testing.

The researchers hope to expand their studies by figuring out how to stimulate multiple parts of the brain at the same time.

Originally posted here:
Researchers Use Genetics and Electromagnetism to Control the Movements of Mice - Futurism

South San Francisco, CA-based Fluidigm Corporation , a leading player in the analysis of single cells and industrial application of genomics, recently announced that it has entered into a licensing agreement with Baylor Genetics.

Per the agreement, Fluidigm licensed the rights to commercialize the CFTR (cystic fibrosis transmembrane conductance regulator) library prep assay developed by Baylor Genetics for research purposes. This would be used with its proprietary Juno automated microfluidic system. The targeted library prep assay enables accurate identification of variants from each of the 27 exons in the CFTR gene and selected intronic regions. When combined with Fluidigm microfluidics, this solution has the potential to significantly simplify complex labor-intensive laboratory workflows and improve the efficiency of CFTR sequencing. This would invariably improve the efficiency of its Juno automated microfluidic system and help the company to capture a considerable market share.

Next-generation sequencing offers a more comprehensive approach to CFTR genetic analysis by allowing a complete view of the sequence. Targeted sequencing library prep workflows, however, can be very labor-intensive. With the application of Fluidigm automated microfluidics technology, library preparation can be streamlined to provide significant efficiencies.

Over the past one month, Fluidigm has underperformed the broader industry. The stock has shed 7.1%, compared with the industrys decline of 3.1%.

Fluidigm develops, manufactures and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single cell genomics. The company caters to leading academic institutions, clinical research laboratories and pharmaceuticals, biotechnology and agricultural biotechnology companies worldwide.

Zacks Rank & Key Picks

Currently, Fluidigm has a Zacks Rank #3 (Hold). A few better-ranked medical stocks are Edwards Lifesciences Corp. (EW - Free Report), Lantheus Holdings, Inc. (LNTH - Free Report) and Align Technology, Inc. (ALGN - Free Report). Edwards Lifesciences and Align Technology sport a Zacks Rank #1 (Strong Buy), while Lantheus Holdings carries a Zacks Rank #2 (Buy). You can see the complete list of todays Zacks #1 Rank stocks here.

Edwards Lifesciences has a long-term expected earnings growth rate of 15.2%. The stock has gained around 3.2% over the last three months.

Lantheus Holdings has a long-term expected earnings growth rate of 12.5%. The stock has gained 66.1% over the last six months.

Align Technology has a long-term expected earnings growth rate of 26.6%. The stock has rallied roughly 29.6% over the last three months.

4 Surprising Tech Stocks to Keep an Eye on

Tech stocks have been a major force behind the markets record highs, but picking the best ones to buy can be tough. Theres a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now before the next wave of innovations really take off.

See Stocks Now>>

Follow this link:
Fluidigm (FLDM) Licenses CFTR Assay From Baylor Genetics - Zacks.com

Sessions and Tracks

Industrial Biotechnology

Industrial biotechnology is the application of biotechnology for industrial purposes, includingindustrial fermentation. The practice of using cells such as micro-organisms, or components of cells like enzymes, to generate industrially useful products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles andbiofuels. Industrial Biotechnology offers a premier forum bridging basic research and R&D with later-stage commercialization for sustainable bio based industrial and environmental applications.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Pharmaceutical Biotechnology

Pharmaceutical Biotechnology is the science that covers all technologies required for producing, manufacturing and registration of biological drugs.Pharmaceutical Biotechnologyis an increasingly important area of science and technology. It contributes in design and delivery of new therapeutic drugs,diagnosticagents for medical tests, and ingene therapyfor correcting the medical symptoms of hereditary diseases. The Pharmaceutical Biotechnology is widely spread, ranging from many ethical issues to changes inhealthcarepracticesand a significant contribution to the development of national economy.Biopharmaceuticalsconsists of large biological molecules which areproteins. They target the underlying mechanisms and pathways of a disease or ailment; it is a relatively young industry. They can deal with targets in humans that are not accessible withtraditional medicines.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan;Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand.

Bioeconomy

Biotechnology is an innovative science in which living systems and organisms are used to develop new and useful products, ranging from healthcare products to seeds. The field ofBiotechnologyis growing rapidly making tremendous impacts in Medical/Health Care, Food & Agriculture. The Global Biotechnology industry is in the growth phase of its economic life cycle. Over the five years to 2014, revenue and industry value added (IVA) growth have outpaced world GDP growth. The Frontiers in Biotechnology track will cover current technological aspects that aim at obtaining products with scientific, industrial, health and agricultural applications, from organisms with increasing levels of complexity from bacteria, yeast, plants, animal cells and virus. With the lectures and demonstrations on stem cell therapy,Embryo transfer technology, next generation sequencing, Drug discovery, biotechnology in food and dairy, etc... The participants are expected to acquire knowledge in techniques and methodologies used in Biotechnology.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Medical Biotechnology

Medicine is by means of biotechnology techniques so much in diagnosing and treating dissimilar diseases. It also gives opportunity for the population to defend themselves from hazardous diseases. The pasture of biotechnology, genetic engineering, has introduced techniques like gene therapy, recombinant DNA technologyand polymerase chain retort which employ genes and DNA molecules to make adiagnosis diseasesand put in new and strong genes in the body which put back the injured cells. There are some applications of biotechnology which are live their part in the turf of medicine and giving good results.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Systems and Synthetic Biotechnology

Systems and Synthetic Biotechnology is the use of laboratory techniques to study and modify nucleic acids and proteins for applications in areas such as human and animal health, agriculture, and the environment.Molecular biotechnologyresults from the convergence of many areas of research, such as molecular biology, microbiology, biochemistry, immunology,genetics, and cell biology. It is an exciting field fueled by the ability to transfer genetic information between organisms with the goal of understanding important biological processes or creating a useful product.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Biotechnology Applications

Biotechnology has application in four major industrial areas, including health care (medical), crop production and agriculture, nonfood (industrial) uses of crops and other products (e.g. biodegradable plastics, vegetable oil, biofuels), and environmental uses. AppliedMicrobiologyand Biotechnology focusses on prokaryotic or eukaryotic cells, relevant enzymes and proteins, applied genetics and molecular biotechnology,genomicsand proteomics, applied microbial and cell physiology, environmental biotechnology, process and products and more.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan;Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand.

Algal Biotechnology

It improves the food we eat - meat, milk and eggs. Biotechnology can improve an animals impact on the environment.Algalbiotechnologyis the use of science and engineering to modify living organisms. The goal is to make products, to improve animals and to developmicroorganismsfor specific agricultural uses. It enhances the ability to detect, treat and prevent diseases, include creating transgenic animals (animals with one or more genes introduced by human intervention), using gene knock out technology to make animals with a specific inactivated gene and producing nearly identical animals by somatic cell nuclear transfer (orcloning).

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Environmental Biotechnology

The biotechnology is applied and used to study the natural environment. Environmental biotechnology could also imply that one try to harnessbiological processfor commercial uses and exploitation. It is "the development, use and regulation of biological systems for remediation of contaminated environment and forenvironment-friendly processes(green manufacturing technologies and sustainable development). Environmental biotechnology can simply be described as "the optimal use of nature, in the form of plants, animals, bacteria, fungi and algae, to producerenewable energy, food and nutrients in a synergistic integrated cycle of profit making processes where the waste of each process becomes the feedstock for another process".

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Nano Biotechnology

Nano biotechnology, bionanotechnology, and Nano biology are terms that refer to the intersection of nanotechnology and biology. Bio nanotechnology and Nano biotechnology serve as blanket terms for various related technologies. The most important objectives that are frequently found inNano biologyinvolve applying Nano tools to relevantmedical/biologicalproblems and refining these applications. Developing new tools, such as peptide Nano sheets, for medical and biological purposes is another primary objective in nanotechnology.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Microbial Biotechnology

Microorganisms have been exploited for their specific biochemical and physiological properties from the earliest times for baking, brewing, and food preservation and more recently for producingantibiotics, solvents, amino acids, feed supplements, and chemical feedstuffs. Over time, there has been continuous selection by scientists of special strains ofmicroorganisms, based on their efficiency to perform a desired function. Progress, however, has been slow, often difficult to explain, and hard to repeat. Recent developments inmolecular biologyand genetic engineering could provide novel solutions to long-standing problems. Over the past decade, scientists have developed the techniques to move a gene from one organism to another, based on discoveries of how cells store, duplicate, and transfer genetic information.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Food Biotechnology

Food processingis a process by which non-palatable and easily perishable raw materials are converted to edible and potable foods and beverages, which have a longer shelf life. Biotechnology helps in improving the edibility, texture, and storage of the food; in preventing the attack of the food, mainly dairy, by the virus like bacteriophage producing antimicrobial effect to destroy the unwanted microorganisms in food that cause toxicity to prevent the formation and degradation of other toxins andanti-nutritionalelements present naturally in food.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Genetic Engineering and Biotechnology

One kind of biotechnology is gene technology, sometimes called 'genetic engineering' or'genetic modification', where the genetic material of living things is deliberately altered to enhance or remove a particular trait and allow the organism to perform new functions. Genes within a species can be modified, or genes can be moved from one species to another. Genetic engineering has applications inmedicine, research, agriculture and can be used on a wide range of plants, animals and microorganisms. It resulted in a series of medical products. The first two commercially prepared products fromrecombinant DNA technologywere insulin andhuman growth hormone, both of which were cultured in the E. coli bacteria.

The field of molecular biology overlaps with biology and chemistry and in particular, genetics and biochemistry. A key area of molecular biology concerns understanding how various cellular systems interact in terms of the way DNA, RNA and protein synthesis function.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan;Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand.

Biotechnology Companies & Market Analysis

From agriculture to environmental science, biotechnology plays an important role in improving industry standards, services, and developing new products. Biotechnology involves the spectrum of life science-based research companies working ontransformative technologiesfor a wide range of industries. While agriculture, material science and environmental science are major areas of research, the largest impact is made in the field medicine. As a large player in the research and development of pharmaceuticals, the role ofbiotechnologyin the healthcare field is undeniable. From genetically analysis and manipulation to the formation of new drugs, many biotech firms are transforming into pharmaceutical and biopharmaceutical leaders.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Biotechnology Capital & Grants

Every new business needs some startup capital, for research, product development and production, permits and licensing and other overhead costs, in addition to what is needed to pay your staff, if you have any. Biotechnology products arise from successfulbiotechcompanies. These companies are built by talented individuals in possession of a scientific breakthrough that is translated into a product or service idea, which is ultimately brought into commercialization. At the heart of this effort is the biotech entrepreneur, who forms the company with a vision they believe will benefit the lives and health of countless individuals. Entrepreneurs start biotechnology companies for various reasons, but creatingrevolutionary productsand tools that impact the lives of potentially millions of people is one of the fundamental reasons why all entrepreneurs start biotechnology companies.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand;Society of Microbial Ecology and Disease, Italy;European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan.

Biotechnology Investor & partnering Forum

The Biotech Investor & Partnering Forum is one of the unique conclave focused on the management and economics ofbiotechnologywhich became so important as the field is growing on a fast paced. From agriculture and environment sectors to pharmaceutical and healthcare products and services, the industries and institutions emerging from the biotech revolution Bio-Based Economy represent one of the largest and most steadily growing building blocks of the Global economy. The social impact is overwhelming, generating tremendous progress in quality of life but also difficult issues that needs responsible management based on consumer &bio-industryperspective, solid ethical principles, growing intellectual property rights complexity, long drug development times, Bio security, unusual market structures and highly unpredictable outcomes are just some of the challenges facing biotechnology management today.

Related Conferences:

International Conference on Agri Biotech and Environmental Engineering, September 11-12, 2017, San Antonio, Texas, USA; 15th Asia-Pacific Biotechnology Congress, July 20-22, 2017, Melbourne, Australia; 17th Euro Biotechnology Congress, September 25-27, 2017, Berlin, Germany; 18th Biotechnology Congress, October 19-20, 2017, Hilton New York JFK Airport Hotel New York, USA; 19th World Congress on Biotechnology, November 13-14, 2017, Osaka, Japan; 2nd World Biotechnology Congress, December 04-05, 2017, Sao Paulo, Brazil; BioTech 2017 Sensor Technology and Online Analytics for (Bio)Process Understanding, September 07-08, 2017, Wadenswil, Switzerland; SBA17 Synthetic Biology Australasia Conference 2017,September 21-22, 2017, Sydney, Australia; ICONAN2017 International Conference On Nanomedicine And Nanobiotechnology, September 25-27, 2017, Barcelona, Spain; The European Forum for Industrial Biotechnology and the Bioeconomy, October 10-11, 2017, Brussels, Belgium; World convention on sustainable biotechnology, October 12-13, 2017, Auckland, Newzealand; EFIB 2017 The European Forum for Industrial Biotechnology and the Bioeconomy, October 19-20 2017, Brussels, Belgium; InnovateBopitech2017 Biotechnology & Industrial Revolution, November 27-28, 2017, Brisbane, Australia.

Related Societies:

European Society for Precision Engineering and Nanotechnology, UK;Indian Society of Nano science And Nanotechnology, India;Iran Society for Cell Biology, Iran;Israel Societies for Experimental Biology, Israel;The Protein Society, USA;International Society for Pharmaceutical Engineering, UK;Malaysian Pharmaceutical Society, Malaysia;Manchester University Pharmaceutical Society, UK;Pharmaceutical Marketing Society, USA;Pharmaceutical Society of Australia, Australia;Pharmaceutical Society of Ireland, Ireland;Pharmaceutical Society of Korea, Korea;Italian Society of Biochemistry and Molecular Biology, Italy;Japanese Society for Quantitative Biology, Japan;Spanish Society of Biotechnology, Spain;Society for Biotechnology, Japan;Mexican Society for Biotechnology and Bioengineering, Mexico;Society for Chemical Engineering Biotechnology, UK;Society for Industrial Microbiology and Biotechnology (SIMB), India;Society for Industrial Microbiology and Biotechnology, India;Tanta Pharmaceutical Scientific Society (TPSS), Egypt;The Pharmaceutical Society of Ireland, Ireland;The Pharmaceutical Society of Korea, Korea;Society for Biological Engineering, USA;Pharmaceutical Society of Singapore, Singapore;Romanian Society of Medical Mycology and Mycotoxicology, Romania;Russian Medical Society, Russia;Korean Society of Food Science And Technology, Korea;Korean Society of Gene and Cell Therapy, Korea;National Society of Agriculture, USA;Society for Engineering in Agriculture, Australia;New Zealand Plant Protection Society, New Zealand.

The rest is here:
Biotechnology Conferences | Biotechnology Events ...

Recent discoveries hold the promise of better detection and treatment of coronary artery disease.

Published: September, 2017

Image: Wavebreakmedia Ltd/Thinkstock

Coronary artery disease the buildup of cholesterol-laden plaque in the heart's arteries is by far the most prevalent life-threatening heart condition. Despite many important discoveries, the genetic influence on this complex condition remains far from clear. But research continues to provide clues that may soon improve both the prediction and the treatment of this common disease beyond current testing of risk factors.

Many different types of heart disease can be passed down through families. Some are caused by just one or a few genetic changes that have a very strong effect in causing disease. Known as monogenic conditions, they include uncommon disorders that mostly affect the heart's muscle (such as hypertrophic cardiomyopathy) or electrical system (such as long QT syndrome). Another example is familial hypercholesterolemia, which causes very high cholesterol levels and may lead to premature coronary artery disease (occurring before age 50).

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

Link:
The genetics of heart disease: An update - Harvard Health

On Aug 11, we issued an updated research report on Salt Lake City, UT-based molecular diagnostics provider, Myriad Genetics, Inc. MYGN . The company currently carries a Zacks Rank #3 (Hold).

For the past three months, Myriad has been trading above the broader industry . The company has rallied 24.7%, compared with the industry's 3.7% gain.

Myriad ended fiscal 2017 on a solid note, with its fourth-quarter numbers exceeding the Zacks Consensus Estimate. The company particularly observed strong growth in EndoPredict and GeneSight testing revenues. Also, Myriad witnessed a third consecutive quarter of rise in hereditary cancer volumes. Also, it received provincial reimbursement in Quebec for EndoPredict.

Notably, at the European League Against Rheumatism (EULAR) meeting held in June in Spain, Crescendo Bioscience, a wholly-owned subsidiary of Myriad, released new data from a meta-analysis of clinical studies. The data has demonstrated the Vectra DA test's ability to predict a joint damage.

The same month, the company announced that its BRACAnalysis CDxcompanion diagnostic test has successfully identified BRCA -mutated patients with HER2- metastatic breast cancer in the OlympiAD trial, who have responded to treatment with olaparib better than standard chemotherapy.

Myriad's collaborations with AstraZeneca and BeiGene for development of companion diagnostics also raise optimism. Moreover, Myriad continues to make progress with its kit-based versions of Prolaris and myPath Melanoma in the international market and expects to file for CE Mark for Prolaris by 2018.

Moreover, the company has introduced its 'Elevate 2020' program that targets to achieve $50 million of incremental operating income by fiscal 2020. Per management, the company has selected the projects that are anticipated to deliver $17 million of operating income in fiscal 2018 and another $24 million in fiscal 2019.

On the flip side, unfavorable currency translation continues to be a major dampener for the stock. Management fears that further strengthening of the dollar against foreign currencies will lead to deteriorating operating results.

Intensifying competition as well as the possibility that Myriad's new test might not generate meaningful profits to outweigh the costs associated with its development continues to raise concern.

Zacks Rank and Key Picks

Some better-ranked medical stocks are Edwards Lifesciences Corp. EW , Steris Plc STE and Align Technology, Inc. ALGN . Edwards Lifesciences and Align Technology sport a Zacks Rank #1 (Strong Buy), while Steris carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here.

Edwards Lifesciences has a positive earnings surprise of 10.75% over the trailing four quarters. The stock has gained around 0.9% over the last three months.

Align Technology has a long-term expected earnings growth rate of 26.6%. The stock has rallied roughly 25.4% over the last three months.

Steris has a positive earnings surprise of 0.78% over two of the trailing four quarters. The stock has gained 13.1% over the last three months.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>

Myriad Genetics, Inc. (MYGN): Free Stock Analysis Report

Align Technology, Inc. (ALGN): Free Stock Analysis Report

STERIS PLC (STE): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Excerpt from:
Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes - Nasdaq